glycine Indications/Contra | FAERs | Orange Book | BioActivity |

Stem definitionDrug idCAS RN
1319 56-40-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • glycine
  • 2-aminoacetic acid
  • aminoacetic acid
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
  • Molecular weight: 75.07
  • Formula: C2H5NO2
  • CLOGP: -3.21
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 2
  • TPSA: 63.32
  • ALOGS: 0.87
  • ROTB: 1

Drug dosage:

None

Approvals:

DateAgencyCompanyOrphan
May 25, 1976 FDA HOSPIRA

FDA Adverse Event Reporting System

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
No adverse event 92.94 62.26 23 189 22140 4616640
Foetal growth restriction 86.17 62.26 15 197 2551 4636229

Pharmacologic Action:

SourceCodeDescription
ATC B05CX03 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
IRRIGATING SOLUTIONS
Other irrigating solutions
CHEBI has role CHEBI:50733 nutraceutical
CHEBI has role CHEBI:62868 hepatoprotective agent
CHEBI has role CHEBI:64571 NMDA receptor agonist
MeSH PA D018684 Glycine Agents
MeSH PA D018377 Neurotransmitter Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Cough indication 49727002
Allergic rhinitis indication 61582004
Nasal discharge indication 64531003
Nasal congestion indication 68235000
Rhinitis indication 70076002 DOID:4483
Common cold indication 82272006 DOID:10459
Classical phenylketonuria contraindication 7573000
Poisoning by digitalis glycoside contraindication 12876009
Constipation contraindication 14760008 DOID:2089
Hyperphosphatemia contraindication 20165001 DOID:0050459
Hypervitaminosis D contraindication 27712000 DOID:9971
Sarcoidosis contraindication 31541009 DOID:11335
Dehydration contraindication 34095006
End stage renal disease contraindication 46177005 DOID:784
Humoral hypercalcemia of malignancy contraindication 47709007
Heart disease contraindication 56265001 DOID:114
Hypercalcemia contraindication 66931009 DOID:12678
Hyperparathyroidism contraindication 66999008 DOID:13543
Ventricular fibrillation contraindication 71908006
Hypercalciuria contraindication 71938000
Kidney disease contraindication 90708001 DOID:557
Kidney stone contraindication 95570007
Osteolysis contraindication 203522001
Arteriosclerosis obliterans contraindication 361133006 DOID:5160

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.21 acidic
pKa2 9.94 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Sodium- and chloride-dependent glycine transporter 1 Transporter IC50 4.50 CHEMBL
Glutamate receptor ionotropic, NMDA 1 Ion channel IC50 6.60 CHEMBL
Glutamate NMDA receptor Ion channel Ki 6.77 CHEMBL

External reference:

IDSource
D005998 MESH_DESCRIPTOR_UI
4017980 VUID
N0000146327 NUI
C0017890 UMLSCUI
D00011 KEGG_DRUG
346464005 SNOMEDCT_US
603 MMSL
4919 RXNORM
15331006 SNOMEDCT_US
4793 MMSL
4017980 VANDF
NOCODE MMSL
000929 NDDF
003191 NDDF
d06640 MMSL
750 PUBCHEM_CID
CHEBI:15428 CHEBI
CHEMBL773 ChEMBL_ID
DB00145 DRUGBANK_ID
TE7660XO1C UNII
630 INN_ID
727 IUPHAR_LIGAND_ID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
ProcalAmine HUMAN PRESCRIPTION DRUG LABEL 22 0264-1915 INJECTION 0.42 g INTRAVENOUS NDA 13 sections
Glycine HUMAN PRESCRIPTION DRUG LABEL 1 0264-2302 IRRIGANT 1.50 g IRRIGATION NDA 12 sections
Plenamine HUMAN PRESCRIPTION DRUG LABEL 17 0264-3200 SOLUTION 1.04 g INTRAVENOUS ANDA 13 sections
Plenamine HUMAN PRESCRIPTION DRUG LABEL 17 0264-3205 SOLUTION 1.04 g INTRAVENOUS ANDA 13 sections
Plenamine HUMAN PRESCRIPTION DRUG LABEL 17 0264-4500 SOLUTION 1.04 g INTRAVENOUS ANDA 13 sections
Glycine HUMAN PRESCRIPTION DRUG LABEL 1 0264-7390 IRRIGANT 1.50 g IRRIGATION NDA 12 sections
FreAmine III HUMAN PRESCRIPTION DRUG LABEL 16 0264-9010 INJECTION, SOLUTION 1.40 g INTRAVENOUS NDA 13 sections
FreAmine III HUMAN PRESCRIPTION DRUG LABEL 16 0264-9011 INJECTION, SOLUTION 1.40 g INTRAVENOUS NDA 13 sections
TrophAmine HUMAN PRESCRIPTION DRUG LABEL 20 0264-9341 SOLUTION 0.36 g INTRAVENOUS NDA 12 sections
FreAmine HBC HUMAN PRESCRIPTION DRUG LABEL 15 0264-9350 INJECTION, SOLUTION 0.33 g INTRAVENOUS NDA 13 sections
TrophAmine HUMAN PRESCRIPTION DRUG LABEL 20 0264-9361 SOLUTION 0.22 g INTRAVENOUS NDA 12 sections
HepatAmine HUMAN PRESCRIPTION DRUG LABEL 16 0264-9371 INJECTION, SOLUTION 0.90 g INTRAVENOUS NDA 13 sections
Glycine HUMAN PRESCRIPTION DRUG LABEL 1 0338-0289 SOLUTION 1.50 g IRRIGATION NDA 11 sections
ProSol HUMAN PRESCRIPTION DRUG LABEL 17 0338-0499 INJECTION, SOLUTION 2.06 g INTRAVENOUS NDA 15 sections
Clinisol HUMAN PRESCRIPTION DRUG LABEL 17 0338-0502 INJECTION, SOLUTION 1.04 g INTRAVENOUS ANDA 11 sections
Travasol HUMAN PRESCRIPTION DRUG LABEL 15 0338-0644 INJECTION 1.03 g INTRAVENOUS NDA 15 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1083 INJECTION 283 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1089 INJECTION 438 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1091 INJECTION 438 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1093 INJECTION 438 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1095 INJECTION 438 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1099 INJECTION 515 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 16 0338-1101 INJECTION 515 mg INTRAVENOUS NDA 14 sections
CLINIMIX HUMAN PRESCRIPTION DRUG LABEL 15 0338-1103 INJECTION 515 mg INTRAVENOUS NDA 14 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1107 INJECTION 283 mg INTRAVENOUS NDA 16 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1109 INJECTION 283 mg INTRAVENOUS NDA 16 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1113 INJECTION 438 mg INTRAVENOUS NDA 16 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1115 INJECTION 438 mg INTRAVENOUS NDA 16 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1119 INJECTION 438 mg INTRAVENOUS NDA 16 sections
CLINIMIX E HUMAN PRESCRIPTION DRUG LABEL 21 0338-1123 INJECTION 515 mg INTRAVENOUS NDA 16 sections